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Abstract
Background: Trachoma control programs utilize mass azithromycin distributions to treat ocular Chlamydia trachomatis as
part of an effort to eliminate this disease world-wide. But it remains unclear what the community-level risk factors are for
infection.
Methods: This cluster-randomized, controlled trial entered 48 randomly selected communities in a 262 factorial design
evaluating the effect of different treatment frequencies and treatment coverage levels. A pretreatment census and
examination established the prevalence of risk factors for clinical trachoma and ocular chlamydia infection including years of
education of household head, distance to primary water source, presence of household latrine, and facial cleanliness (ocular
discharge, nasal discharge, and presence of facial flies). Univariate and multivariate associations were tested using linear
regression and Bayes model averaging.
Findings: There were a total of 24,536 participants (4,484 children aged 0–5 years) in 6,235 households in the study. Before
treatment in May to July 2010, the community-level prevalence of active trachoma (TF or TI utilizing the World Health
Organization [WHO] grading system) was 26.0% (95% CI: 21.9% to 30.0%) and the mean community-level prevalence of
chlamydia infection by Amplicor PCR was 20.7% (95% CI: 16.5% to 24.9%) in children aged 0–5 years. Univariate analysis
showed that nasal discharge (0.29, 95% CI: 0.04 to 0.54; P= 0.03), presence of flies on the face (0.40, 95% CI: 0.17 to 0.64;
P= 0.001), and years of formal education completed by the head of household (0.07, 95% CI: 0.07 to 0.13; P= 0.03) were
independent risk factors for chlamydia infection. In multivariate analysis, facial flies (0.26, 95% CI: 0.02 to 0.49; P= 0.03) and
years of formal education completed by the head of household (0.06, 95% CI: 0.008 to 0.11; P= 0.02) were associated risk
factors for ocular chlamydial infection.
Interpretation: We have found that the presence of facial flies and years of education of the head of the household are risk
factors for chlamydia infection when the analysis is done at the community level.
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Introduction
Background
Trachoma is an ocular infection caused by Chlamydia trachomatis.
The World Health Organization (WHO) has implemented
treatment guidelines that include mass antibiotic administration,
facial cleanliness campaigns and environmental improvements in
an effort to control and ultimately eliminate the disease [1]. The
risk factors for infection are poorly characterized on a community
level. This study establishes a knowledge base that assesses these
community-level risk factors in an effort to guide the WHO and
other programmatic efforts. Some of the risk factors thought to be
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predictive of trachoma include facial cleanliness (nasal or ocular
discharge and presence of flies on the face), access to a latrine,
access to clean water, and education. Many studies have identified
individual-level risk factors, such as hygiene and latrine use [2,3],
but trachoma is a communicable disease with community-level
risk factors and treatment. Individuals can be affected by their
neighbors, regardless of whether they themselves are compliant
with their prescribed antibiotic treatment or adherent with other
recommended environmental changes. Here, we analyze commu-
nity-level risk factors for ocular chlamydia infection in Niger in an
effort to improve trachoma control and elimination strategies. In
this arm of the Partnership for the Rapid Elimination of
Trachoma (PRET) trial [4,5], we assess 48 communities before
treatment and determine the importance of several community-
level risk factors for ocular chlamydial infection.
Methods
Study Setting and Design
Niger, in the Sahel region of West Africa, is one of the poorest
and least developed countries in the world, ranking in the bottom
1% of countries in the 2010 United Nations Human Development
Index [6]. Trachoma is endemic within Niger’s population of
roughly 14 million [7], with estimated regional prevalences of
between 5% and 49% in children aged 1–9 years [8]. Our study
methods have been previously described [4] and are briefly
summarized below.
Site Selection
In Niger, contiguous administrative units are known as grappes,
and are referred to as communities in this manuscript. A community
is the smallest population unit for which health services are
organized and within which trachoma programs are implement-
ed. The study took place in the Matameye district in the Zinder
region of Niger. Communities were selected from among 6 health
centers (Centre de Sante´ Inte´gre´e or CSIs) and were eligible for
inclusion if they had an estimated total population of between 250
to 600 persons, generally encompassing between 50 and 100
children in the eligible age range for treatment. Other community
inclusion criteria were distance .4 kilometers from the center of
any semi-urban area (communities which are close to an urban
center are believed to have a lower prevalence of trachoma), and
prevalence of active trachoma (TF and/or TI)$10% in children
aged 0–5 years. There were a total of 235 eligible communities in
the 6 CSIs of which 72 (31%) satisfied the inclusion criteria for
community size and 48 of these were selected for inclusion in the
study.
Community Randomization Arms
In a 262 factorial design, 48 communities were randomly
allocated into 4 treatment arms with 12 communities in each arm
(Figure 1). Randomization of communities and sentinel individuals
to the treatment arms was done using RANDOM and SORT
functions in Excel (Version 2003) by TP and BN. Note that only
pretreatment results are presented here.
Communities and Sentinel Children
To determine the impact of mass antibiotic administration on
clinical trachoma and ocular chlamydia infection, a random
sample of 50 to 100 children aged 0 to 5 years was established as
the sentinel group for the study in all enrolled communities prior
to treatment. No adjustments were made for missing individuals
from the census and all analyses were performed at the community
level on an intention-to-treat basis.
Data Collection
Baseline data were collected on the following measures:
trachoma clinical grade, facial cleanliness, ocular swabs, and
ocular photographs. Grader validation was done in a 2-step
process: in the first step, research leaders attended a workshop
conducted in February 2008 in Ethiopia where trachoma is hyper-
endemic, to standardize methods for the trial. Certification of
researchers for trachoma grading required a chance corrected
agreement (kappa statistic $0.6) with an experienced grader (RB)
over the scoring signs of clinically active trachoma (TF and/or TI
in the WHO system) in validation exercises in both the classroom
(photographic collection) and the field. In the second step, clinical
graders in Niger were eligible to perform ocular grading for the
trial if they had attained a chance corrected agreement (kappa
statistic $0.6) with a certified grader over the scoring signs of
clinically active trachoma. The pretreatment visit for this trial was
conducted in Niger from May to July 2010, where 3 ophthalmic
nurses (TSO’s, or Technicien Superior en Ophtalmologie)
received a kappa score on photo grading validation of 0.96, 1.00
and 0.88 (against senior grader RB).
Census
A population census of all 48 study communities was conducted
by trained personnel, masked to the treatment arm, prior to the
baseline visit. Study personnel were also masked to the prevalence
of clinical trachoma and ocular chlamydia infection. The census
team moved from house to house, enumerating all residents in
all households, collecting baseline characteristics information.
The 100% census allowed us to create a sampling frame from
which we could randomly select sentinel children with equal
probabilities.
Examination
After obtaining consent, conjunctival examination for trachoma
and conjunctival swabbing for chlamydial PCR were performed
on all sentinel children [9,10]. Clinical grading of the right everted
superior tarsal conjunctiva was performed using a 2.56 magni-
fying loupe and adequate sunlight or a torch light according to the
WHO simplified grading system [11]. Prior to conjunctival
Author Summary
Trachoma is one of the most important neglected tropical
diseases because it is the leading cause of blindness from
an infection in the world. There are about 1.3 million
persons blind from the disease and many more at risk of
blindness in the future. It is caused by the common
bacterium Chlamydia trachomatis and can be treated with
mass drug administrations (MDA) of azithromycin. We
have begun a clinical trial in Niger, a country with limited
resources in Africa, to determine the best treatment
strategy. Our study from May to July 2010, which began
before MDA’s were given, showed that 26% of children
aged 0–5 years were infected with the disease. In these
children, we found that discharge from the nose, presence
of flies on the face, and the number of years of education
completed by the head of the household were risk factors
for infection in 48 different communities. We hope to use
this information about risk factors of infection to help
guide future studies for trachoma and also to help with the
WHO goal of eliminating the disease worldwide by the
year 2020.
Risk Factors for Ocular Chlamydia Infection
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swabbing, a trained photographer took a minimum of 2
photographs of the right eyelid of all child participants using a
Nikon D-series camera and a Micro Nikon 105 mm; f/2.8 lens
(Nikon, Tokyo, Japan).
After conjunctival examination, a Dacron swab was passed
firmly 3 times over the right upper tarsal conjunctiva, rotating 120
degrees between each pass [9,10]. To assess for field contamina-
tion, negative field control swabs were collected from 5 randomly
selected children in each community. The negative field controls
were collected immediately after the ocular swabs were collected; a
new swab was passed within 5 cm of, but not contacting, the
participant’s exposed conjunctiva [9]. Examiners changed gloves
before examining each new participant. All of the samples were
placed immediately at 4uC in the field and frozen at220uC within
10 hours. Swabs were shipped at 4uC to University of California,
San Francisco, CA, USA, where they were stored at 280uC until
processing [12]. The Amplicor PCR assay (Roche Diagnostics,
Branchburg, NJ, USA) was used to detect C. trachomatis DNA and
samples were pooled for processing to save time and cost, as
previously described [13]. For laboratory standardization and
validation between PRET study sites, a set of 20 samples (both
positive and negative) was sent to a laboratory at Johns Hopkins
University (Baltimore, MD, USA) for processing. Results were
considered valid only when agreement between labs was at least
90%.
Risk Factors
During the census, community-level data were collected on
household characteristics, including number of years of education
completed by head of household; distance to the primary water
source .30 min walk; presence of a latrine; and awareness of a
programmatic face-washing campaign in the community within
the previous year. Facial cleanliness was measured for each child
who presented for an exam, including the presence of ocular
discharge (on the eyelashes or eyelids), nasal discharge (on nares,
cheeks, or lips), and presence of flies on face (presence of $1 fly on
the face while observing for 3 seconds).
Statistical Methods
Data were entered into a database (MS Access v2007)
developed at the Dana Center, Johns Hopkins University as
previously described [5]. Data were double-entered by different
data entry clerks and discrepancies were resolved by reference to
the original forms. Queries of all data discrepancies were identified
using MS Access prior to any analysis. The intention-to-treat
statistical analysis was performed using the statistical package R
(http://www.r-project.org), 2.12 for MacIntosh. All pretreatment
characteristics were summarized at the community level. Univar-
iate associations with ocular chlamydia infection in children aged
0–5 years were tested using linear regression, with permutation-
based significance testing because of non-normality. Multivariate
regression was conducted using demographic and clinical (non-
trachoma) predictors by selecting the best univariate predictors (no
more than 4 included predictors, because the number of
communities was only 48). Because stepwise regression may result
in overfitting [14], we used Bayes model averaging based on the
Bayes information criterion to conduct multiple regression (R
package BMA, v. 3.14) [15]. This technique yields estimates for
each regression coefficient and a posterior probability that each
differs from zero (posterior effect probabilities). Because of
heteroskedasticity of the outcome variable, we reported confidence
intervals derived from bootstrap resampling of the residuals
following ordinary linear regression [16] (with 10,000 replications)
for each regression coefficient.
Human Participants and Consent Procedures
Ethical approval for this study was obtained from the
Committee for Human Research of the University of California,
San Francisco and le Comite Consultatif National d’Ethique du
Ministere de la Sante Publique, Niger (Ethical Committee, Niger
Ministry of Health). Oral consent was obtained from the village
leaders, and written (thumbprint) consent from the study
participant (or the child’s parent or guardian) at the time of
examination. The study was carried out in accordance with the
Declaration of Helsinki. An independent data and safety
monitoring committee appointed by the PRET study executive
committee oversaw the design and implementation of the study
and performed annual reviews of quality assurance and adverse
events.
Results
Overview of Communities and Households
The 48 randomly selected communities included 24,536 total
individuals in 6,235 households (Table 1). Exams were conducted
and ocular swabs collected from a total of 4,484 children aged 0–5
years from May to July 2010. The mean prevalence of clinical
trachoma (TF) was 26.0% (95% CI: 21.9% to 30.0%) and the
mean prevalence of ocular C. trachomatis infection was 20.7% (95%
CI: 16.5% to 24.9%) in the 48 communities (Table 2). The
community-level prevalence of infection and the community-level
prevalence of TF were highly correlated (Pearson correlation 0.63,
95% CI: 0.42 to 0.78; P,0.001).
Field Controls and Laboratory Standardization
A total of 238 negative field control swabs were collected; 12
(5.0%) were PCR positive for chlamydia. As part of a quality
control investigation, it was determined that 11 of these 12 (91.7%)
field controls were collected by a single examiner and steps were
immediately taken to improve the field training for specimen
collection in all field workers to reduce contamination. All positive
field controls had corresponding positive ocular swabs. The pre-
specified level of agreement between laboratories at UCSF and
Johns Hopkins University was maintained at .90%.
Risk Factors for Ocular Chlamydia Infection - Univariate
Analysis
In the univariate model (Table 3) using simple linear regression,
there was increased risk of ocular chlamydia infection in
communities where children had nasal discharge (0.29, 95% CI:
0.04 to 0.54; P=0.03) or flies on the face (0.40, 95% CI: 0.17 to
0.64; P=0.001). Other significant predictors of chlamydia
infection were years of education of the head of household (0.07,
95% CI: 0.007 to 0.13; P=0.03), proportion of children aged 0 to
1 year (20.96, 95% CI: 21.73 to 20.19; P=0.02) and prevalence
of clinical trachoma TF (0.65, 95% CI: 0.42 to 0.88; P,0.001)
(Table 3).
Risk Factors for Ocular Chlamydia Infection - Multivariate
Analysis
In the multivariate analysis using Bayes model averaging
(Table 4), among the measured risk factors, chlamydia infection
in communities was associated only with flies on face (0.26, 95%
CI: 0.02 to 0.49, P=0.03) and level of education of head of
household (0.06, 95% CI: 0.008 to 0.11, P=0.02). Other
characteristics, including gender, ocular discharge, nasal dis-
charge, number of individuals per household, water access
.30 mins, and latrine access, were not significant risk factors in
Risk Factors for Ocular Chlamydia Infection
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Figure 1. Consort flow diagram: cluster-randomized trachoma trial in Niger.
doi:10.1371/journal.pntd.0001586.g001
Risk Factors for Ocular Chlamydia Infection
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this model. Ordinary linear regression gave confidence intervals
which were slightly wider than those derived from bootstrap
resampling.
Discussion
We have found that communities with higher percentages of
younger children, nasal discharge, facial flies, and number of years
of education of the head of the household are associated with
higher community prevalence of chlamydia infection in univariate
analysis. Community-level facial flies and years of education of
head of household are significantly associated with the prevalence
of chlamydia infection in multivariate analysis. Flies are thought to
be important in trachoma transmission but studies have been done
only on the individual level [2,5,17–19] or have used clinical
outcomes rather than more objective laboratory measurements
[2,17,18]. Chlamydia DNA has been found on 15% of flies in
areas hyperendemic for trachoma [20] and so flies are believed to
be vectors for the spread of chlamydia in endemic areas [21]. Our
study is the first to show the association between community-level
fly density flies and community-level ocular chlamydia infection.
Other studies performed on the individual-level have concluded
that general education is associated with less trachoma [5,22–25],
but our study in Niger found the opposite and chlamydia infection
was correlated directly with the self- reported years of education of
the head of the household. Trachoma is felt to be disease which
aggregates among the poor and uneducated [26], and studies have
shown health education can improve trachoma control [27].
However, a study in Mali showed the odds of trachoma was higher
in households where children attended a traditional school
compared to households where children attended a modern
school. Mali shares a border with Niger of greater than 860 km
and is likely more similar to Niger than more distant areas. The
structure of the schools and the way in which children congregate
in these schools is just as important as the years of education that
have been received.
Table 1. Baseline characteristics of cluster-randomized trial in
Niger.
Characteristic
Communities 48
Total population 24,536
Households 6,235
Children in study1 4,484
Persons/household, median (IQR) 7 (6)
Households .30 mins to water 355; 5.7%, (4.9% to 6.7%)
Households with latrine access 667; 10.7%, (9.6% to 11.9%)
Community prevalence children1 28.2% (27.6% to 28.8%)
Community prevalence male children1 49.5% (48.3% to 50.1%)
95% confidence intervals in parentheses, unless otherwise noted.
1Aged 0–5 years.
doi:10.1371/journal.pntd.0001586.t001
Table 2. Characteristics in children aged 0–5 years in 48
communities in Niger.
Characteristic
Mean prevalence TF1 26.0% (21.9% to 30.0%)
Mean prevalence TF/TI2 28.3% (24.1% to 32.4%)
Mean prevalence C. trachomatis3 20.7% (16.5% to 24.9%)
Pearson correlation between TF & infection 0.63 (0.42 to 0.78), P,0.001
Pearson correlation between TF/TI & infection 0.71 (0.53 to 0.83), P,0.001
All values with 95% confidence intervals in parentheses.
1TF = trachomatous inflammation, follicular.
2TI = trachomatous inflammation, intense.
3C. trachomatis by Amplicor PCR.
doi:10.1371/journal.pntd.0001586.t002
Table 3. Univariate analysis of chlamydia infection predictors in children 0–5 years in 48 communities in Niger.
Prevalence of characteristic Coefficient R-squared P-value
Proportion female 0.44 (20.51 to 1.40) 0.02 0.38
Proportion 0 or 1 years 20.96 (21.73 to 20.19) 0.11 0.02
Ocular Discharge1 0.19 (20.03 to 0.41) 0.06 0.10
Nasal Discharge2 0.29 (0.04 to 0.54) 0.10 0.03
Flies on face3 0.40 (0.17 to 0.64) 0.20 0.001
Mean no. of persons/household 0.003 (20.01 to 0.02) 0.003 0.73
Mean no.years of education completed by head
of household
0.07 (0.007 to 0.13) 0.09 0.03
Time to water source .30 min walk 20.03 (20.29 to 0.23) 0.001 0.85
Latrine presence 0.13 (20.19 to 0.45) 0.01 0.43
Number of households (1000) 0.29 (20.99 to 1.58) 0.004 0.66
Education program 0.10 (20.05 to 0.25) 0.04 0.20
Prevalence TF 0.65 (0.42 to 0.88) 0.40 P,0.001
Prevalence TI 1.61 (1.19 to 2.03) 0.55 P,0.001
Prevalence TF or TI 0.71 (0.51 to 0.92) 0.50 P,0.001
1On eyelashes or eyelids.
2On nares, cheeks or lips.
3Presence of $1 fly on the face during a 3-second examination.
doi:10.1371/journal.pntd.0001586.t003
Risk Factors for Ocular Chlamydia Infection
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We have used community-level predictors and community-level
outcomes because trachoma is a communicable disease; poor
hygiene and specific behavior of others in the same household and
neighborhood may increase the risk of infection in the entire
community [26,28–30]. For these reasons the WHO strategy for
reducing trachoma is implemented at the community level with
community-wide interventions. Other trachoma studies have been
cluster-randomized but then analyzed at the level of the individual
[10,27,31]. Like our study in Niger, the Tanzania arm of the
PRET study found that facial flies are associated with ocular
chlamydia infection [5]. However, this individual-level study also
showed that facial cleanliness is a risk for ocular chlamydia
infection, an association which we were unable to identify.
Reinfection is known to occur at the community level and an
individual-level approach does not take this into account. In our
study, we look for risk factors for higher community prevalence of
ocular chlamydia infection.
The clinical exam for trachoma has been shown to be unreliable
and poorly correlated with infection in some situations [32–34].
We chose to use the more objective, masked, outcome of ocular
chlamydia infection by PCR in our study. Note that we did include
the clinical exam in the multivariate predictor model of infection
by design, because TF and TI are consequences of infection rather
than causes of it. However, in a different context, programs that
have access to clinical surveys may be interested in the associated
level of infection that we have measured here (Table 5). It is
important to keep in mind the clinical exam for trachoma (TF) is
close to 90% sensitive but only 30% specific in latent class analysis,
leading to overtreatment in some situations [35]. Furthermore, the
poor correlation between the clinical signs of trachoma and the
laboratory evidence of infection with C. trachomatis, becomes more
problematic as the community-level of infection decreases
following mass treatment [36]. Nevertheless, the clinical exam is
inexpensive and easy to perform. It will remain an important tool
for the WHO in their treatment guidelines and continued efforts to
understand the relationship between clinical trachoma and
infection with the causative bacteria is critical.
There are several limitations to this study. First, we evaluated
only a sample of sentinel children in the communities rather than
all individuals and this may have produced bias in our estimates.
Note that laboratory workers were masked to the identities of the
sentinel children chosen and the communities in which they lived.
Second, although all of the selected communities for inclusion in
the study were evaluated successfully as planned, some individuals
who were randomly selected for inclusion were missing; if
individuals were not missing at random, this could also have
created bias. All analyses were done on an intention-to-treat basis
with no adjustments for missing individuals. Third, the evidence
for risk factors of infectious ocular chlamydia that we have found
in rural Niger may not be generalizable to other trachoma-
endemic areas in other countries and continents because of
differences in important, unmeasured cultural or environmental
characteristics. The finding that more years of education of the
head of household is associated with higher levels of chlamydia
infection is counterintuitive. The study questionnaire asked
specifically for the number of years of formal education that were
completed. Religious education, a form of learning that is very
common in this area, was not included in this estimate. If the
education of adults is by methods other than formal education in
households, our measurement could have been an underestimate
of the total amount of education interfering with our ability to
capture an association with infection.
In summary, we have found that facial flies and years of
education of the head of the household are associated with
community-level prevalence of ocular chlamydia infection.
Further analyses will be performed as treatment begins in the
study and continues over the next 3 years.
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